TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2010

Consolidation therapy with subcutaneous alemtuzumab after fludarabine and rituximab induction therapy for previously untreated chronic lymphocytic leukemia: final analysis of CALGB 10101.

Thomas S Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.